Axa’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-782,085
Closed -$1.24M 1108
2023
Q1
$1.24M Sell
782,085
-6,281
-0.8% -$32.4K ﹤0.01% 838
2022
Q4
$4.91M Buy
+788,366
New +$5.64M 0.02% 607
2021
Q2
Sell
-127,146
Closed -$3.57M 1264
2021
Q1
$3.57M Buy
127,146
+36,874
+41% +$1.09M 0.01% 759
2020
Q4
$2.35M Buy
90,272
+71,877
+391% +$2.15M 0.01% 824
2020
Q3
$684K Sell
18,395
-186
-1% -$7.37K ﹤0.01% 991
2020
Q2
$953K Buy
18,581
+953
+5% +$39.9K ﹤0.01% 964
2020
Q1
$556K Sell
17,628
-64,632
-79% -$3.41M ﹤0.01% 952
2019
Q4
$4.91M Buy
+82,260
New +$3.7M 0.02% 623
2018
Q2
Sell
-4,700
Closed -$340K 1363
2018
Q1
$340K Buy
+4,700
New +$345K ﹤0.01% 1233
2015
Q4
Sell
-117,703
Closed -$2.78M 1424
2015
Q3
$2.78M Buy
117,703
+39,612
+51% +$2.49M 0.01% 707
2015
Q2
$6.38M Hold
78,091
0.03% 527
2015
Q1
$7.23M Sell
78,091
-10,455
-12% -$675K 0.03% 478
2014
Q4
$3.58M Buy
+88,546
New +$2.71M 0.01% 645

Other funds holding ESPR